investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors

Michelle Hildebrandt

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Simon A Gayther

The Contribution of Rare Alleles to Ovarian Cancer in the Population

Ovary

Pathology

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Ovary

Celeste Leigh Pearce

Mechanisms of Prevention of Ovarian Cancer by Oral Contraceptives

Ovary

Pathology

Susan J Ramus

Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer

Ovary

Pathology

Lesley M Butler

Urinary Metalloproteinases and Ovarian Cancer Risk in a Prospective Cohort

Ovary

Pathology

Joanne S. Richards

Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis

Ovary

Pathology

Andre Michael Lieber

Evaluation of Vectors Based on Group B Adenoviruses

Ovary

Pathology

Sandra Orsulic

(PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women

Ovary

Ross L Prentice

Nutrition and Physical Activity Assessment Study (NPAAS)

Ovary